US Broker Ratings

Brookdale Senior Living Inc. (BKD): Navigating Challenges with a 4.80% Revenue Growth in Healthcare

Brookdale Senior Living Inc. (NYSE: BKD) stands as a significant player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $1.98 billion, the..

Supernus Pharmaceuticals (SUPN): Investor Outlook on a Rising Biopharma Star with Potential Upside

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) is carving out a notable niche within the healthcare sector, particularly in the specialty and generic drug manufacturing industry. With a market capitalization of $2.67..

Recursion Pharmaceuticals (RXRX) Stock Analysis: A Biotech Gem with 31.70% Potential Upside

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) is making waves in the biotechnology sector with its innovative approach to drug discovery. Operating as a clinical-stage biotech company, Recursion is leveraging cutting-edge technology..

Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: Exploring a Potential 129.55% Upside

For investors with a keen eye on the biotechnology sector, Edgewise Therapeutics, Inc. (NASDAQ: EWTX) presents a compelling opportunity with its substantial upside potential. The company, which focuses on pioneering..

Mirum Pharmaceuticals, Inc. (MIRM): Investor Outlook Highlights Robust Revenue Growth and Analyst Confidence

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM), a biopharmaceutical company based in Foster City, California, has been capturing the attention of investors with its innovative approach to treating rare and orphan diseases...

Artivion, Inc. (AORT) Stock Analysis: Navigating a 5.95% Potential Upside in the Medical Device Sector

Artivion, Inc. (AORT), a prominent player in the medical devices industry, is drawing significant interest from investors eager to tap into its promising growth potential. With a market capitalization of..

MoonLake Immunotherapeutics (MLTX) Stock Analysis: Unpacking a Potential 712% Upside in the Biotech Arena

MoonLake Immunotherapeutics (NASDAQ: MLTX), a burgeoning force in the biotechnology sector, is capturing the attention of investors with its ambitious pipeline and the potential for significant stock appreciation. Based in..

NewAmsterdam Pharma (NAMS) Stock Analysis: A Biotech Gem with Nearly 49% Upside

NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS), a dynamic player in the biotechnology sector, is capturing the attention of investors with its promising therapeutic developments and substantial growth potential. Headquartered in..

Centessa Pharmaceuticals (CNTA) Stock Analysis: A Potential 31.89% Upside in Biotechnology

Investors with an eye on the biotechnology sector may find Centessa Pharmaceuticals plc (NASDAQ: CNTA) a compelling opportunity, especially with analysts forecasting a potential upside of 31.89%. This clinical-stage biopharmaceutical..

ImmunityBio, Inc. (IBRX) Stock Analysis: A 296.89% Potential Upside Captures Investor Attention

ImmunityBio, Inc. (NASDAQ: IBRX) is making waves in the biotechnology sector with a remarkable potential upside of nearly 297%, according to current analyst ratings. This San Diego-based biotech firm is..

Travere Therapeutics, Inc. (TVTX) Stock Analysis: Exploring a 49.75% Potential Upside in Biotech

For investors with a keen interest in the biotechnology sector, Travere Therapeutics, Inc. (NASDAQ: TVTX) presents an intriguing opportunity. This San Diego-based biopharmaceutical company operates in the highly specialized arena..

Mesoblast Limited (MESO): Investor Outlook Highlights 68.54% Potential Upside

Mesoblast Limited (NASDAQ: MESO), a key player in the biotechnology sector, is currently capturing investor attention with a compelling potential upside of 68.54%, based on its current stock price and..

Azenta, Inc. (AZTA) Investor Outlook: Navigating the Healthcare Sector with a 17% Upside Potential

Azenta, Inc. (AZTA), a key player in the healthcare sector, focuses on providing innovative sample exploration and management solutions for the life sciences industry. Based in Burlington, Massachusetts, Azenta operates..

Denali Therapeutics Inc. (DNLI) Stock Analysis: Exploring a Potential 116.94% Upside in Biotechnology

Denali Therapeutics Inc. (NASDAQ: DNLI) stands at the forefront of the biotechnology sector, focusing on the discovery and development of therapeutics for neurodegenerative and lysosomal storage diseases. With a market..

QuidelOrtho Corporation (QDEL) Stock Analysis: Exploring a 39.66% Potential Upside for Savvy Investors

QuidelOrtho Corporation (NASDAQ: QDEL), a significant player in the healthcare sector, particularly within the medical devices industry, presents an intriguing opportunity for investors seeking exposure to diagnostic testing solutions. With..

PROCEPT BioRobotics (PRCT) Stock Analysis: Exploring a 79.78% Potential Upside in the Medical Device Sector

PROCEPT BioRobotics Corporation (NASDAQ: PRCT), a key player in the medical device sector, is capturing the attention of investors with its innovative solutions in urology. Headquartered in San Jose, California,..

Kymera Therapeutics, Inc. (KYMR) Stock Analysis: Unveiling the Potential Upside Amidst a Robust Buy Rating Consensus

For investors looking to tap into the dynamic world of biotechnology, Kymera Therapeutics, Inc. (NASDAQ: KYMR) presents an intriguing opportunity. With a market capitalization of $4.18 billion, this clinical-stage biopharmaceutical..

Acadia Healthcare Company, Inc. (ACHC) Stock Analysis: Exploring a 24.87% Upside Potential

Acadia Healthcare Company, Inc. (NASDAQ: ACHC), a leader in the behavioral healthcare sector, presents a compelling opportunity for investors seeking exposure to the healthcare industry. With a market capitalization of..

Progyny, Inc. (PGNY) Stock Analysis: Exploring a 31.89% Potential Upside in the Healthcare Sector

Progyny, Inc. (PGNY), a prominent player in the healthcare sector, stands out with its innovative fertility and family-building benefits solutions. Headquartered in New York, the company has carved a niche..

GoodRx Holdings, Inc. (GDRX) Stock Analysis: Unpacking a 25% Potential Upside in Healthcare Innovation

GoodRx Holdings, Inc. (NASDAQ: GDRX) stands at an intriguing juncture for investors seeking opportunities in the dynamic healthcare sector. With a market capitalization of $1.4 billion, this U.S.-based company has..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds